COVID-19: Frequently Asked Questions: asymptomatic infection, re-infection, immunity, and GP management of patients with COVID-19 test results from a laboratory other than the public laboratory service. [v2.4]
dc.contributor.author | Health Protection Surveillance Centre | |
dc.date.accessioned | 2022-01-24T10:59:58Z | |
dc.date.available | 2021-01-26T15:27:09Z | |
dc.date.available | 2021-04-13T10:58:46Z | |
dc.date.available | 2021-04-19T14:14:08Z | |
dc.date.available | 2021-04-23T09:51:58Z | |
dc.date.available | 2021-06-11T13:27:55Z | |
dc.date.available | 2021-07-07T13:42:53Z | |
dc.date.available | 2021-10-01T09:10:08Z | |
dc.date.available | 2021-10-13T09:12:41Z | |
dc.date.available | 2022-01-24T10:59:58Z | |
dc.date.issued | 2022-01-21 | |
dc.identifier.uri | http://hdl.handle.net/10147/628851 | |
dc.description | These FAQs are based on HIQA evidence syntheses, public health and clinical evidence summaries which have informed the HIQA-Expert Advisory Group (EAG) available at https://www.hiqa.ie/areas-we-work/health-technology-assessment/covid-19-publications. They also include advice and decisions of the former COVID-19 EAG (Jan-Sept 2020) and the HSE Antigen Detection Testing (ADT) group. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Service Executive | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | INFECTION PREVENTION AND CONTROL | en_US |
dc.subject | PUBLIC HEALTH | en_US |
dc.title | COVID-19: Frequently Asked Questions: asymptomatic infection, re-infection, immunity, and GP management of patients with COVID-19 test results from a laboratory other than the public laboratory service. [v2.4] | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2021-01-26T15:27:10Z |